
    
      A prospective, multi-center, single arm, open-label clinical trial to evaluate the safety and
      IOP lowering performance of the AqueSys Microfistula Implant in refractory glaucoma patients
      who have previously failed a glaucoma procedure and who are not well-controlled on IOP
      lowering medications.
    
  